Goupil Rémi, Wolley Martin, Ahmed Ashraf H, Gordon Richard D, Stowasser Michael
Endocrine Hypertension Research Centre, University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane, Qld, Australia.
Hôpital du Sacré-Coeur de Montréal, University of Montréal, Montréal, QC, Canada.
Clin Endocrinol (Oxf). 2015 Oct;83(4):456-61. doi: 10.1111/cen.12750. Epub 2015 Mar 17.
Demonstration of unilateral aldosterone production by adrenal venous sampling (AVS) is required to select appropriate candidates for adrenalectomy in patients with primary aldosteronism (PA). During AVS, aldosterone and cortisol levels are measured to assess successful cannulation and lateralization. In patients with aldosterone-producing adenoma (APA), concurrent autonomous cortisol secretion might confound AVS results.
We retrospectively examined results in eight patients with cortisol-producing adenoma (CPA), but without PA, who underwent AVS.
In all eight, cortisol was higher on the CPA side than contralateral (CL) (median 6·7-fold [range 2·4-27·2]; P = 0·012]). By cortisol criteria, CL catheter placement would have been labelled inadequate in six despite adrenal venous aldosterone levels markedly higher than peripheral (41·6-fold [7·2-510·5]; P < 0·001), suggesting successful cannulation. In all eight, adrenal venous aldosterone/cortisol (A/C) ratios on the CL side were indicative of increased aldosterone production (≥2 times peripheral), but in only three patients on the CPA side (difference CL side 44·5-fold [6·0-109·0] vs CPA side 1·65-fold [1·0-23·0]; P = 0·017). A/C ratios were higher on the CL vs the CPA side in seven (20·0-fold [4·7-76·0]).
These results in patients with CPA suggest that in patients with APA, concurrent autonomous unilateral cortisol hypersecretion could confound AVS accuracy by increasing cortisol levels (reducing A/C ratio) on the CPA side, while reducing levels (increasing A/C ratio and suggesting failed cannulation) on the CL side. Misclassification of PA subtype or repeat AVS could result, underscoring the importance of adequately assessing cortisol production prior to AVS and the need to consider alternatives.
对于原发性醛固酮增多症(PA)患者,需要通过肾上腺静脉采血(AVS)来证实单侧醛固酮分泌,以选择合适的肾上腺切除术候选人。在AVS过程中,测量醛固酮和皮质醇水平以评估插管是否成功及进行侧别定位。在醛固酮瘤(APA)患者中,同时存在的自主性皮质醇分泌可能会混淆AVS结果。
我们回顾性研究了8例患有皮质醇瘤(CPA)但无PA的患者的AVS结果。
在所有8例患者中,CPA侧的皮质醇水平高于对侧(CL)(中位数为6.7倍[范围2.4 - 27.2];P = 0.012)。按照皮质醇标准,尽管肾上腺静脉醛固酮水平明显高于外周水平(41.6倍[7.2 - 510.5];P < 0.001),提示插管成功,但仍有6例患者的CL导管放置会被标记为不合适。在所有8例患者中,CL侧的肾上腺静脉醛固酮/皮质醇(A/C)比值表明醛固酮分泌增加(≥外周水平的2倍),但CPA侧只有3例患者如此(CL侧差异为44.5倍[6.0 - 109.0],而CPA侧为1.65倍[1.0 - 23.0];P = 0.017)。7例患者CL侧的A/C比值高于CPA侧(20.0倍[4.7 - 76.0])。
CPA患者的这些结果表明,在APA患者中,同时存在的自主性单侧皮质醇分泌增多可能会通过提高CPA侧的皮质醇水平(降低A/C比值)而混淆AVS的准确性,同时降低CL侧的水平(增加A/C比值并提示插管失败)。这可能导致PA亚型的错误分类或重复进行AVS,强调了在AVS之前充分评估皮质醇分泌的重要性以及考虑其他替代方法的必要性。